VitaNova Life Sciences (VNOV) Total Current Liabilities (2017 - 2026)
VitaNova Life Sciences (VNOV) reported Total Current Liabilities of $457975.0 for Q1 2026, up 115.22% on a YoY basis from $212789.0 in Q1 2025, and up 4.55% quarter-over-quarter from $438051.0 in Q4 2025.
VitaNova Life Sciences (VNOV) Total Current Liabilities (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported Total Current Liabilities for 10 years, with the latest figure at $457975.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 115.22% year-over-year to $457975.0; the trailing twelve-month figure through Jan 2026 stood at $457975.0 (up 115.22% YoY), and the FY2025 full-year result was $347567.0, up 153.85% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $457975.0, up from $438051.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $457975.0 in Q1 2026, with the low at $50491.0 in Q1 2022.
- Historically, Total Current Liabilities has averaged $178611.2 across 5 years, with a median of $93574.0 in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 66.74% — and 2025, when it soared 153.85%.
- VitaNova Life Sciences' Total Current Liabilities stood at $65443.0 in 2022, then jumped by 40.91% to $92217.0 in 2023, then surged by 142.84% to $223938.0 in 2024, then jumped by 95.61% to $438051.0 in 2025, then climbed by 4.55% to $457975.0 in 2026.
- The last three Total Current Liabilities figures came in at $457975.0 (Q1 2026), $438051.0 (Q4 2025), and $379975.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 12.02 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 67.02 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 56.13 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 41.99 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 1.20 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.51 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 275.45 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 34.08 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 457,975.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 457,975.00 |
| Oct 31, 2025 | 438,051.00 |
| Jul 31, 2025 | 379,975.00 |
| Apr 30, 2025 | 347,567.00 |
| Jan 31, 2025 | 212,789.00 |
| Oct 31, 2024 | 223,938.00 |
| Jul 31, 2024 | 199,374.00 |
| Apr 30, 2024 | 136,920.00 |
| Jan 31, 2024 | 93,574.00 |
| Oct 31, 2023 | 92,217.00 |
| Jul 31, 2023 | 83,462.00 |
| Apr 30, 2023 | 67,943.00 |
| Jan 31, 2023 | 65,843.00 |
| Oct 31, 2022 | 65,443.00 |
| Jul 31, 2022 | 62,738.00 |
| Apr 30, 2022 | 58,091.00 |
| Jan 31, 2022 | 50,491.00 |
| Oct 31, 2021 | 48,791.00 |
| Jul 31, 2021 | 32,107.00 |
| Apr 30, 2021 | 174,670.00 |